Replies to post #137676 on Cytodyn Inc (CYDY)

[ClosetInvestor]

“I think NP has already stated they would release unblinded data on the 14th.”

I don’t recall NP mentioning that exact date, but the full enrollment PR stated, “The 390-patient data will be analyzed in approximately 28 days, with expected results to be announced shortly thereafter.”

https://www.cytodyn.com/newsroom/press-releases/detail/491/cytodyn-completes-enrollment-for-phase-3-registrational

Completion of the 28th day is the 12th of January and the 14th is a few days later, but that seems rushed to publish such important results. NP typically over promises, but a decent amount, so I expect the data to be released a week or two after the 12th. CYDY needs to take their time to fully analyze the data and publish a through and well thought out PR discussing the results. We don’t need a repeat of the two different M2M PRs, spread 3 weeks apart, of which one had to be released a second time a few hours later. That was a debacle.

[misiu143]

Badge, - actually FDA , or at least some people do follow our EIND ,M/M and S/C study,

I exchanged few e-mails with Dr Janet Woodcock , I send her some information from Dr Patterson paper , also our CD10 and interim CD12 ..

She knew what is going on already ...

According to the company , our analysis of unblinded study will be send to FDA and they will ask for EUA , since this should take less time..
Analysis may take couple of weeks , from the time of unblinding at January 12......

After , hopefully we will have EUA , company will start to file papers for full approval..

This was a plan according to last couple CCs , and it is a logical move imo.